A cure for baldness could be the golden egg for big pharmaceutical companies

Men all around the world suffering from male pattern baldness should be ecstatic to hear that scientists believe within two years a cure for baldness will be on store shelves. While the cure may appeal mostly to men, the fix for thinning hair will likely be appropriate for women as well.

For people suffering from baldness, the follicles still make hair, but in smaller amounts compared to years past. The scientists say that hair gets shorter and shorter until the hairs are barely visible or don't break the surface of the skin.

According to scientists involved with the research, talks are already underway with pharmaceutical companies to make a product that would be a lotion designed to halt the effects of a single enzyme. Earlier this year, dermatologists from the U.S. announced that they had located an enzyme called prostaglandin D2 (PGD2) that is responsible for telling hair follicles to stop producing hair.

During the research, scientist George Cotsarelis, head of dermatology at Pennsylvania University, and his team determined that and 17 men participating in their study who had hair loss also had PGD2 levels were three times higher in bald spots than in areas producing hair.

According to the scientists, drugs designed to reduce the levels of PGD2 are already available on the market because that same enzyme has been implicated in asthma attacks.

There is no doubt that the market for such a product would be huge, as four out of five men will experience some degree of baldness by age 70.

The worst is: the pharmaceutical probably already has a cure for baldness, for decades now. The problem is: the pharmaceutical industry isn't interested in providing a cure. It's interested in providing a treatment. And that's the hard part: provide some drug, that when applied regularly treats the condition, but when stopped also let's the condition to return. That's why most drugs in this area fail. And that's why drugs are called drugs. Because they're supposed to be addictive, thus guaranteeing continous profit for the meg pharm corps.

The thing is baldness is probably mostly genetic so unless you start speaking of genetic therapy there will never be a permanent cure but only temporary fixes, even in this case it will probably be something that works on that specific enzyme but since we keep producing it chances are we would need to apply the treatment on a daily/weekly bases.

It's true the pharmaceuticals are more interested in thing temporary fixes however if the find a permanent fix they will sell it anyways, this cause if you have found it someone else may find it too and you may end up being caught off guard.